Forma Therapeutics Garners $25,500,000 Series B Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d4303b05-0ce9-4cac-bb84-8d9d30b4336a&Preview=1 -
Date
12/1/2009 -
Company Name
Forma Therapeutics -
Mailing Address
790 Memorial Drive Cambridge, MA 02139 -
Company Description
FORMA Therapeutics is a biopharmaceutical company integrating transformative biology and chemistry to unlock targets and pathways that have been validated through genomic medicine as root causes or major drivers of human cancers. -
Website
http://www.formatherapeutics.com -
Transaction Type
Venture Equity -
Transaction Amount
$25,500,000 -
Transaction Round
Series B -
Proceeds Purposes
“With this new funding, FORMA will focus on advancing our internal target-based oncology programs and in parallel, we will continue to pursue non-dilutive collaborations to further build our integrated drug discovery platform,” said Steven Tregay, CEO of FORMA. -
M&A Terms
-
Venture Investor
Lilly Ventures -
Venture Investor
Novartis Venture Fund -
Venture Investor
Bio*One Capital
